BTD
HQL

BankPlus Trust Department’s abrdn Life Sciences Investors HQL Stock Holding History

BankPlus Trust Department’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.7K Hold
2,134
– – 0.01% 294
2025
Q4 		$35.8K Hold
2,134
– – 0.01% 280
2025
Q3 		$33.1K Hold
2,134
– – 0.01% 280
2025
Q2 		$27.3K Hold
2,134
– – 0.01% 283
2025
Q1 		$27.1K Hold
2,134
– – 0.01% 281
2024
Q4 		$28K Buy
+2,134
New +$30.8K 0.01% 273

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BankPlus Trust Department's HQL Position: Q1 2026 in Review

BankPlus Trust Department held its abrdn Life Sciences Investors (HQL) position steady in Q1 2026 at 2,134 shares worth $34.7K. The position accounts for 0.01% of the portfolio, ranked #294.

BankPlus Trust Department first reported a position in HQL in Q4 2024 and has held it in 6 quarters since. The position peaked at $35.8K in Q4 2025. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • BankPlus Trust Department held 2,134 shares of abrdn Life Sciences Investors worth $34.7K as of Q1 2026.
  • BankPlus Trust Department left its abrdn Life Sciences Investors share count unchanged in Q1 2026.
  • abrdn Life Sciences Investors made up 0.01% of BankPlus Trust Department's portfolio in Q1 2026, its #294 holding.
  • BankPlus Trust Department first reported a position in abrdn Life Sciences Investors in Q4 2024 and has held it in 6 quarters since.
  • BankPlus Trust Department's abrdn Life Sciences Investors position peaked at $35.8K in Q4 2025.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on BankPlus Trust Department's 13F filing for Q1 2026, filed 11 May 2026.